International Cancer Imaging Society


Our Journal - Cancer Imaging

Our Journal 1

Our Journal 1

Cancer Imaging is the official journal of ICIS, an open access, peer-reviewed journal published by BioMed Central. Original articles, as well as reviews and editorials written by international imaging experts with a subspecialty focus on oncology, are published regularly online;  sign up for alerts to keep up-to-date with the latest articles.  Alongside the 2013 impact factor of 1.29, Cancer Imaging is pleased to announce the 5-year impact factor of 1.76, enhanced by a very favourable Immediacy Index score.  

The journal encompasses CT, MRI, ultrasound, single photon and positron emission tomography, including multimodality imaging in all kinds of malignant tumours, plus new developments, techniques and innovations.

All articles published in Cancer Imaging are included in PubMed, the most widely used biomedical bibliographic database service, as well as Embase, EmCare, Google Scholar, MEDLINE, Science Citation Index and Scopus. The full text of all research articles is deposited in PubMed Central, the US National Library of Medicine's full-text repository of life science literature.

ICIS Members receive 15% discount on article-processing fees.

Submit your next manuscript to Cancer Imaging and take full advantage of the following:

Our Journal 4


Members Area


Subscribe to our mailing list

* indicates required
Email Format

Cancer / Oncology News From Medical News Today

Breast cancer 'is not a single disease,' say experts

Published: Tue, 31 Mar 2015 14:00:00 GMT

A new report from the National Cancer Institute and other bodies claims breast cancer consists of four subtypes, and incidence of these subtypes varies by age and other factors.

Vanderbilt researchers identify potential new anti-cancer drug target

Published: Tue, 31 Mar 2015 09:00:00 GMT

Vanderbilt University researchers have discovered a cleft in a chromosome-binding protein that may hold the key to stopping most cancers in their tracks.

New role uncovered for 'oldest' tumor suppressor gene

Published: Tue, 31 Mar 2015 08:00:00 GMT

Scientists have revealed a brand new function for one of the first cancer genes ever discovered - the retinoblastoma gene - in a finding that could open up exciting new approaches to treatment.

Promising drug target identified in medulloblastoma

Published: Tue, 31 Mar 2015 08:00:00 GMT

Scientists at Dana-Farber/Boston Children's Cancer and Blood Disorders Center have identified a protein critical to both the normal development of the brain and, in many cases, the development of...

Newly updated treatment guidelines for medullary thyroid carcinoma

Published: Tue, 31 Mar 2015 07:00:00 GMT

A Task Force convened by the American Thyroid Association (ATA) released updated guidelines for the diagnosis and treatment of medullary thyroid carcinoma (MTC).

Higher coffee consumption may protect against liver cancer

Published: Mon, 30 Mar 2015 15:00:00 GMT

Evidence has emerged from the World Cancer Research Fund International CUP report on liver cancer that finds drinking coffee may reduce the risk of liver cancer.

Hexvix fluorescence-guided bladder resection: Recently published data demonstrate favorable overall survival outcome in bladder cancer patients

Published: Mon, 30 Mar 2015 10:00:00 GMT

Ipsen is pleased to note that a study on the impact of Hexvix® on survival in bladder cancer patients has been recently published in the World Journal of Urology1.Dr.

Blocking cellular quality control mechanism gives cancer chemotherapy a boost

Published: Mon, 30 Mar 2015 08:00:00 GMT

A University of Rochester team found a way to make chemotherapy more effective, by stopping a cellular quality-control mechanism, according to a study published today in Nature Communications.

Global Oncology launches Global Cancer Project Map for cancer research access with NCI

Published: Mon, 30 Mar 2015 07:00:00 GMT

Nonprofit Global Oncology, Inc. (GO) have announced the launch of the Global Cancer Project Map, a first-of-its-kind online resource and virtual information exchange for connecting the global...

Sugar-seeking MRI could be used to detect early-stage cancer

Published: Sun, 29 Mar 2015 07:00:00 GMT

Johns Hopkins researchers are trialling a new MRI technique to detect early-stage cancer, guide biopsies and monitor chemotherapy response.

News

27 February 2015

Registration opens for London 2015

Registration opens for London 2015


Prof. And ...
» Read more » Other news items